Literature DB >> 22470417

Circulating hepatitis B surface antigen particles carry hepatocellular microRNAs.

Luisa Novellino1, Riccardo L Rossi, Ferruccio Bonino, Daniela Cavallone, Sergio Abrignani, Massimiliano Pagani, Maurizia R Brunetto.   

Abstract

Hepatitis B virus (HBV) produces high quantities of subviral surface antigen particles (HBsAg) which circulate in the blood outnumbering virions of about 1\10(3-6) times. In individuals coinfected with the defective hepatitis Delta virus (HDV) the small HDV-RNA-genome and Delta antigen circulate as ribonucleoprotein complexes within HBsAg subviral particles. We addressed the question whether subviral HBsAg particles may carry in the same way cellular microRNAs (miRNAs) which are released into the bloodstream within different subcellular forms such as exosomes and microvescicles. Circulating HBsAg particles were isolated from sera of 11 HBsAg carriers by selective immunoprecipitation with monoclonal anti-HBs-IgG, total RNA was extracted and human miRNAs were screened by TaqMan real-time quantitative PCR Arrays. Thirty-nine human miRNAs were found to be significantly associated with the immunoprecipitated HBsAg, as determined by both comparative DDCT analysis and non-parametric tests (Mann-Whitney, p<0.05) with respect to controls. Moreover immunoprecipitated HBsAg particles contained Ago2 protein that could be revealed in ELISA only after 0.5% NP40. HBsAg associated miRNAs were liver-specific (most frequent = miR-27a, miR-30b, miR-122, miR-126 and miR-145) as well as immune regulatory (most frequent = miR-106b and miR-223). Computationally predicted target genes of HBsAg-associated miRNAs highlighted molecular pathways dealing with host-pathogen. The finding that HBsAg particles carry selective pools of hepatocellular miRNAs opens new avenues of research to disentangle the complex interactions between host and HBV and provides a non invasive tool to study the physiopathology of liver epigenetics.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22470417      PMCID: PMC3314627          DOI: 10.1371/journal.pone.0031952

Source DB:  PubMed          Journal:  PLoS One        ISSN: 1932-6203            Impact factor:   3.240


  25 in total

1.  MicroRNAs control hepatocyte proliferation during liver regeneration.

Authors:  Guisheng Song; Amar Deep Sharma; Garrett R Roll; Raymond Ng; Andrew Y Lee; Robert H Blelloch; Niels M Frandsen; Holger Willenbring
Journal:  Hepatology       Date:  2010-05       Impact factor: 17.425

Review 2.  MicroRNA control in the immune system: basic principles.

Authors:  Changchun Xiao; Klaus Rajewsky
Journal:  Cell       Date:  2009-01-09       Impact factor: 41.582

Review 3.  microRNAs: fad or future of liver disease.

Authors:  Ashley M Lakner; Herbert L Bonkovsky; Laura W Schrum
Journal:  World J Gastroenterol       Date:  2011-05-28       Impact factor: 5.742

4.  Circulating microRNAs, miR-21, miR-122, and miR-223, in patients with hepatocellular carcinoma or chronic hepatitis.

Authors:  Jian Xu; Chen Wu; Xu Che; Li Wang; Dianke Yu; Tongwen Zhang; Liming Huang; Hui Li; Wen Tan; Chengfeng Wang; Dongxin Lin
Journal:  Mol Carcinog       Date:  2010-12-10       Impact factor: 4.784

5.  Deregulation of microRNA expression occurs early and accumulates in early stages of HBV-associated multistep hepatocarcinogenesis.

Authors:  Peng Gao; Carmen Chak-Lui Wong; Edmund Kwok-Kwan Tung; Joyce Man-Fong Lee; Chun-Ming Wong; Irene Oi-Lin Ng
Journal:  J Hepatol       Date:  2010-10-31       Impact factor: 25.083

6.  Circulating microRNAs in hepatitis B virus-infected patients.

Authors:  F Ji; B Yang; X Peng; H Ding; H You; P Tien
Journal:  J Viral Hepat       Date:  2011-03-07       Impact factor: 3.728

7.  Argonaute2 complexes carry a population of circulating microRNAs independent of vesicles in human plasma.

Authors:  Jason D Arroyo; John R Chevillet; Evan M Kroh; Ingrid K Ruf; Colin C Pritchard; Donald F Gibson; Patrick S Mitchell; Christopher F Bennett; Era L Pogosova-Agadjanyan; Derek L Stirewalt; Jonathan F Tait; Muneesh Tewari
Journal:  Proc Natl Acad Sci U S A       Date:  2011-03-07       Impact factor: 11.205

Review 8.  Deficiencies in the standardization and sensitivity of diagnostic tests for hepatitis B virus.

Authors:  W H Gerlich; D Glebe; C G Schüttler
Journal:  J Viral Hepat       Date:  2007-11       Impact factor: 3.728

9.  MicroRNAs are transported in plasma and delivered to recipient cells by high-density lipoproteins.

Authors:  Kasey C Vickers; Brian T Palmisano; Bassem M Shoucri; Robert D Shamburek; Alan T Remaley
Journal:  Nat Cell Biol       Date:  2011-03-20       Impact factor: 28.824

10.  Real-time quantification of microRNAs by stem-loop RT-PCR.

Authors:  Caifu Chen; Dana A Ridzon; Adam J Broomer; Zhaohui Zhou; Danny H Lee; Julie T Nguyen; Maura Barbisin; Nan Lan Xu; Vikram R Mahuvakar; Mark R Andersen; Kai Qin Lao; Kenneth J Livak; Karl J Guegler
Journal:  Nucleic Acids Res       Date:  2005-11-27       Impact factor: 16.971

View more
  30 in total

Review 1.  Host functions used by hepatitis B virus to complete its life cycle: Implications for developing host-targeting agents to treat chronic hepatitis B.

Authors:  Bidisha Mitra; Roshan J Thapa; Haitao Guo; Timothy M Block
Journal:  Antiviral Res       Date:  2018-08-24       Impact factor: 5.970

Review 2.  Extracellular RNA in aging.

Authors:  Douglas F Dluzen; Nicole Noren Hooten; Michele K Evans
Journal:  Wiley Interdiscip Rev RNA       Date:  2016-08-17       Impact factor: 9.957

Review 3.  Intercellular transport of microRNAs.

Authors:  Reinier A Boon; Kasey C Vickers
Journal:  Arterioscler Thromb Vasc Biol       Date:  2013-02       Impact factor: 8.311

Review 4.  MicroRNAs as possible biomarkers for diagnosis and prognosis of hepatitis B- and C-related-hepatocellular-carcinoma.

Authors:  Sirio Fiorino; Maria Letizia Bacchi-Reggiani; Michela Visani; Giorgia Acquaviva; Adele Fornelli; Michele Masetti; Andrea Tura; Fabio Grizzi; Matteo Zanello; Laura Mastrangelo; Raffaele Lombardi; Luca Di Tommaso; Arrigo Bondi; Sergio Sabbatani; Andrea Domanico; Carlo Fabbri; Paolo Leandri; Annalisa Pession; Elio Jovine; Dario de Biase
Journal:  World J Gastroenterol       Date:  2016-04-21       Impact factor: 5.742

Review 5.  Complex interactions between microRNAs and hepatitis B/C viruses.

Authors:  Hong-Xia Fan; Hua Tang
Journal:  World J Gastroenterol       Date:  2014-10-07       Impact factor: 5.742

6.  Circulating miRNAs: cell-cell communication function?

Authors:  A Turchinovich; T R Samatov; A G Tonevitsky; B Burwinkel
Journal:  Front Genet       Date:  2013-06-28       Impact factor: 4.599

7.  Extracellular circulating viral microRNAs: current knowledge and perspectives.

Authors:  Alessandro Laganà; Francesco Russo; Dario Veneziano; Sebastiano Di Bella; Rosalba Giugno; Alfredo Pulvirenti; Carlo M Croce; Alfredo Ferro
Journal:  Front Genet       Date:  2013-06-24       Impact factor: 4.599

8.  Hepatitis B virus-specific miRNAs and Argonaute2 play a role in the viral life cycle.

Authors:  C Nelson Hayes; Sakura Akamatsu; Masataka Tsuge; Daiki Miki; Rie Akiyama; Hiromi Abe; Hidenori Ochi; Nobuhiko Hiraga; Michio Imamura; Shoichi Takahashi; Hiroshi Aikata; Tomokazu Kawaoka; Yoshiiku Kawakami; Waka Ohishi; Kazuaki Chayama
Journal:  PLoS One       Date:  2012-10-16       Impact factor: 3.240

9.  Circulating microRNAs: promising candidates serving as novel biomarkers of acute hepatitis.

Authors:  Natalia Elfimova; Martin Schlattjan; Jan-Peter Sowa; Hans Peter Dienes; Ali Canbay; Margarete Odenthal
Journal:  Front Physiol       Date:  2012-12-21       Impact factor: 4.566

Review 10.  Exosomal microRNAs as diagnostic and therapeutic biomarkers in non-malignant liver diseases.

Authors:  Seonghwan Hwang; Yoon Mee Yang
Journal:  Arch Pharm Res       Date:  2021-06-24       Impact factor: 4.946

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.